Cargando…

Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway: Anti-metastatic mechanism of Jinfukang on lung cancer

Detalles Bibliográficos
Autores principales:	Yang, Yun, Zhu, Lihua, Liu, Jiajun, Yu, Pan, Que, Zujun, Li, Yan, Li, Hegen, Tian, Jianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679872/ https://www.ncbi.nlm.nih.gov/pubmed/37723875 http://dx.doi.org/10.3724/abbs.2023148

Ejemplares similares

Genome-Wide Profiling Reveals That Herbal Medicine Jinfukang-Induced Polyadenylation Alteration Is Involved in Anti-Lung Cancer Activity
por: Kou, Yao, et al.
Publicado: (2017)

Bone Marrow Derived Mesenchymal Stem Cells Involve in the Lymphangiogenesis of Lung Cancer and Jinfukang Inhibits the Involvement In Vivo
por: Zhou, Xian-Mei, et al.
Publicado: (2017)

Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells
por: Lu, Jun, et al.
Publicado: (2018)

Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity
por: Lu, Jun, et al.
Publicado: (2016)

Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients?: A protocol for a double-blind, randomized controlled trial
por: Zheng, Xing, et al.
Publicado: (2021)

Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells
por: Que, Zujun, et al.
Publicado: (2019)

New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
por: Que, Zujun, et al.
Publicado: (2022)

Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation
por: Que, Zujun, et al.
Publicado: (2023)

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
por: Que, Zujun, et al.
Publicado: (2019)

Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer
por: Luo, Bin, et al.
Publicado: (2023)

Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
por: Luo, Bin, et al.
Publicado: (2022)

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR–TKIs
por: Melosky, Barbara, et al.
Publicado: (2014)

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
por: Zhang, Zhanxia, et al.
Publicado: (2021)

Size dependent anti-invasiveness of silver nanoparticles in lung cancer cells
por: Que, Yu Mei, et al.
Publicado: (2019)

Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
por: Imamura, Fumio, et al.
Publicado: (2016)

Can we cure metastatic EGFR-mutated lung cancer today?
por: Christopoulos, Petros
Publicado: (2023)

Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
por: Li, Shih-Hong, et al.
Publicado: (2022)

Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma
por: Zhao, Huan, et al.
Publicado: (2017)

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6
por: Wu, Yi-Long, et al.
Publicado: (2017)

Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns
por: Hu, Fang, et al.
Publicado: (2019)

Exploratory Evaluation of EGFR-Targeted Anti-Tumor Drugs for Lung Cancer Based on Lung-on-a-Chip
por: Tan, Jianfeng, et al.
Publicado: (2022)

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma
por: Liu, Xiang-Liang, et al.
Publicado: (2021)

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features
por: Gu, Liyan, et al.
Publicado: (2022)

Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib
por: Yanagisawa, Atsushi, et al.
Publicado: (2022)

Invasive Aspergillosis Mimicking Metastatic Lung Cancer
por: Vanfleteren, Michiel J. E. G. W., et al.
Publicado: (2018)

SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR
por: Yang, Pan, et al.
Publicado: (2022)

Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis
por: Lesma, Elena, et al.
Publicado: (2015)

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
por: Thomas, Brian J., et al.
Publicado: (2023)

The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs
por: Sun, Li, et al.
Publicado: (2019)

Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs
por: Chen, Ying‐Yuan, et al.
Publicado: (2021)

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer
por: Huang, Wei-Lun, et al.
Publicado: (2015)

Applications of cell-free circulating tumor DNA detection in EGFR mutant lung cancer
por: Bulbul, Ajaz, et al.
Publicado: (2020)

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
por: Sun, Wei, et al.
Publicado: (2015)

Baseline Plasma EGFR Circulating Tumour DNA Levels in a Pilot Cohort of EGFR-Mutant Limited-Stage Lung Adenocarcinoma Patients Undergoing Radical Lung Radiotherapy
por: Chia, Brendan Seng Hup, et al.
Publicado: (2020)

The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
por: Cheng, Wen-Chien, et al.
Publicado: (2021)

Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancer
por: Wei, Bing, et al.
Publicado: (2014)

Metastatic Lung Adenocarcinoma Harboring an EGFR-Activating Mutation in a Heart Transplant Recipient
por: Zambrano Mendoza, Elizabeth, et al.
Publicado: (2017)

Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report
por: Wang, Yong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vo6chhlnlcu9rkgfq8q34phkkc